Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications considerations characterizing real‐world data relevance quality regulatory purposes
Understanding Treatment Trends for Chronic Lymphocytic Leukemia Time trends in frontline systemic therapy utilization for chronic lymphocytic leukemia in the United States Goyal R, Nagar S, Davis KL, Kaye JA Transcript: Targeted treatments have emerged …
Locations Image click to see larger version of map With offices located around the globe, RTI-HS is truly an international and diverse organization. Working alongside a multinational and multidisciplinary team of colleagues will afford you a unique …
JCA Development and Support We can be your expert partner for education and guidance throughout the whole development process including JCA impact on your product pipeline. We can help you with: JCA dossier and evidence refinement Post-submission support …
Benefits In addition to our vibrant culture and career development resources, we offer employees robust benefits packages and a rewards program designed to recognize individual and team achievement. From comprehensive insurance plans to stellar retirement …
… therapeutic areas. She also has experience with primary data collection, including telephone, mailed, in-person, and …
… literature reviews, targeted literature reviews, and data source mapping reviews. She has worked on projects in a …
… Alissa Zellner Quality Headquarters - Research Triangle Park, North …
… outcomes strategy and generating and analyzing outcomes data. Additionally, Ms. Masaquel has experience in medical … implants. She has previous experience with healthcare quality and medical informatics research and medical claims …
… U.S. The survey was conducted in collaboration with market-data research firm Plant-A Insights. “We are thrilled to be … with family responsibilities. Newsweek and market-data research firm Plant-A Insights are proud to introduce …
Infectious Disease Models Utilize the power of infectious disease models to inform your analyses and help you better understand the potential impact of your novel healthcare intervention. You rely on realistic disease models to understand and communicate …